Related Experiment Video
Updated: Nov 12, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
Using recurrent time-to-event models with multinomial outcomes to generate toxicity profiles.
Val Gebski1, Ian Marschner1, Rebecca Asher1
1National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Camperdown, New South Wales, Australia.
This study introduces toxicity profiles to track adverse events over time during long-term cancer therapy. This method helps assess treatment safety and effectiveness, especially for new therapies like targeted treatments and immunotherapy.
Area of Science:
- Clinical pharmacology
- Biostatistics
- Oncology
Background:
- Clinical studies often report adverse event frequencies but lack temporal data.
- Understanding the timing of adverse events is crucial for managing long-term therapies and assessing new treatments.
- Current methods do not fully capture the dynamic nature of treatment-related toxicities.
Purpose of the Study:
- To develop and illustrate a method for generating 'toxicity profiles' that detail the temporal patterns of adverse events.
- To enable simultaneous assessment of event risks over time and provide cumulative probabilities for different adverse event types.
- To aid in disease management and the evaluation of novel therapeutic agents.
Main Methods:
- An adaptation of the ordinal time-to-event model was used.
- A two-step process involved multinomial logistic regression for response probabilities.
- These were combined with recurrent time-to-event hazard estimates to produce cumulative event probabilities.
Main Results:
- The developed method generates detailed toxicity profiles for adverse events.
- Cumulative event probabilities for each adverse event category were calculated.
- Toxicity profiles were illustrated for three adverse events in advanced breast cancer patients receiving two treatment regimens.
Conclusions:
- The proposed method provides a robust tool for analyzing the temporal aspects of adverse events.
- Toxicity profiles can enhance the assessment of therapeutic interventions, particularly long-term treatments.
- This approach supports better clinical decision-making and evaluation of treatment benefits versus costs.
Related Concept Videos
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time...
Mutagenicity and Carcinogenicity
Analysis of Population Pharmacokinetic Data
Comparing the Survival Analysis of Two or More Groups
Multicompartment Models: Overview
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...

